# Alterations in epigenetic marks and expression of genes related to stress regulation: an exploratory study among newborns after fetal repair of spina bifida aperta

**Authors:** M. A. Landolt, N. L. Strebel, U. Moehrlen, N. Ochsenbein, N. Strübing, T. Burkhardt, C. D’Addario, M Pucci, A. Bodenmann, E. Grünblatt

PMC · DOI: 10.1080/15592294.2026.2632976 · 2026-03-08

## TL;DR

This study explores molecular changes in newborns who underwent fetal repair for spina bifida, focusing on genes involved in stress regulation.

## Contribution

The study identifies gene- and site-specific epigenetic and gene expression differences in newborns after fetal spina bifida repair.

## Key findings

- Significant differences in FKBP5 methylation were observed at specific CpG sites in the fSBA group compared to controls.
- NR3C1 gene expression was elevated in the fSBA group, while FKBP5 expression did not differ between groups.
- Molecular variations suggest potential stress-related alterations following fetal interventions.

## Abstract

Fetal repair of spina bifida aperta (fSBA) is an established intervention that improves neurological and neurodevelopmental outcomes. The present exploratory study examines whether molecular signatures related to stress regulation are detectable in newborns following this procedure. Specifically, we investigated DNA methylation and gene expression of two stress-regulatory genes, NR3C1 and FKBP5. Within a clinical trial (ID: NCT04027374), we analyzed postpartum saliva samples from newborns who had undergone fSBA repair (fSBA group; n = 30) and compared them with two control groups: newborns exposed to antenatal glucocorticoids for lung maturation (LMI group; n = 12) and healthy controls (HC group; n = 27). Pyrosequencing and qRT-PCR were used for epigenetic and transcriptional analyses. Significant group differences were observed in FKBP5 methylation, particularly at intron 7 CpG sites 5–7. The fSBA group showed lower methylation at site 5 but higher methylation at sites 6–7 compared to controls. No significant methylation differences were detected for NR3C1. Conversely, NR3C1 gene expression was elevated in the fSBA group, whereas FKBP5 expression did not differ between groups. These findings suggest gene- and site-specific molecular variation in newborns following fetal surgery. Given the exploratory nature of the study, the results are not suited to draw specific clinical implications but may inform future work aimed at understanding stress-related molecular alterations surrounding fetal interventions. Larger and longitudinal studies are warranted to clarify the robustness, developmental course, and potential clinical relevance of these molecular patterns.

## Linked entities

- **Genes:** NR3C1 (nuclear receptor subfamily 3 group C member 1) [NCBI Gene 2908], FKBP5 (FKBP prolyl isomerase 5) [NCBI Gene 2289]
- **Diseases:** spina bifida aperta (MONDO:0017062)

## Full-text entities

- **Genes:** ACTB (actin beta) [NCBI Gene 60] {aka BKRNS, BNS, BRWS1, CSMH, DDS1, PS1TP5BP1}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, FKBP5 (FKBP prolyl isomerase 5) [NCBI Gene 2289] {aka AIG6, FKBP51, FKBP54, P54, PPIase, Ptg-10}, Fkbp5 (FK506 binding protein 5) [NCBI Gene 14229] {aka D17Ertd592e, Dit1, FKBP-5, FKBP51}, PPIA (peptidylprolyl isomerase A) [NCBI Gene 5478] {aka CYPA, CYPH, HEL-S-69p}, HSD11B2 (hydroxysteroid 11-beta dehydrogenase 2) [NCBI Gene 3291] {aka AME, AME1, HSD11K, HSD2, SDR9C3}, Nr3c1 (nuclear receptor subfamily 3, group C, member 1) [NCBI Gene 14815] {aka GR, Grl-1, Grl1}, NR3C1 (nuclear receptor subfamily 3 group C member 1) [NCBI Gene 2908] {aka GCCR, GCR, GCRST, GR, GRL}, RPL13A (ribosomal protein L13a) [NCBI Gene 23521] {aka L13A, TSTA1, uL13}
- **Diseases:** spina bifida aperta (MESH:D016137), spina bifida (MESH:D016135), death (MESH:D003643), preterm birth (MESH:D047928), premature rupture of membranes (MESH:D005322), depression (MESH:D003866), postoperative (MESH:D019106), neurodevelopmental disorders (MESH:D002658), maternal (MESH:D000079262), conduct problems (MESH:D019973), disability (MESH:D009069), congenital anomalies (MESH:D000013), inflammation (MESH:D007249), trauma (MESH:D014947), congenital malformations (OMIM:163000), LMI (MESH:D008171), psychiatric and (MESH:D001523), anxiety (MESH:D001007), Myelomeningocele (MESH:D008591), hypoxic (MESH:D002534), HPA-axis (MESH:D007029), PTSD (MESH:D013313), maternal distress (MESH:D012128), neural tube defects (MESH:D009436), major depressive disorder (MESH:D003865), hypoxia (MESH:D000860)
- **Chemicals:** fSBA (-), dexamethasone (MESH:D003907), nicotine (MESH:D009538), SYBR Green (MESH:C098022), alcohol (MESH:D000438), cortisol (MESH:D006854), lactate (MESH:D019344)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090], Nicotiana tabacum (American tobacco, species) [taxon 4097]
- **Mutations:** rs1360780

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12973468/full.md

---
Source: https://tomesphere.com/paper/PMC12973468